Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Thyrocare Technologies Ltd

NSE: THYROCARE · BSE: 539871 · Healthcare · 12 announcements

Share price
₹566.85
Market cap
₹9,022 Cr
Revenue (annual)
₹829.0 Cr
Net profit (annual)
₹163.0 Cr
P/E (TTM)
51.2×Sector 57.8×
Promoter holding
60.92%+0.00% QoQ
FII holding
5.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:44 IST BSE
Employee Stock Options

Thyrocare Technologies Employee Stock Options

Thyrocare Technologies Limited has granted 1,92,000 employee stock options to eligible employees under the company's approved stock option scheme.

14:57 IST BSE
Merger & Restructuring

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare's board approved sale of 100% in Nueclear Healthcare to Trovera for ~₹141.40 Crore. The move exits radiology to refocus on core pathology business.

Value
₹141.4 Cr
Execution
On or before November 30, 2026